vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and Volato Group, Inc. (SOAR). Click either name above to swap in a different company.
Volato Group, Inc. is the larger business by last-quarter revenue ($24.9M vs $13.8M, roughly 1.8× Gossamer Bio, Inc.). Volato Group, Inc. runs the higher net margin — 14.5% vs -342.3%, a 356.8% gap on every dollar of revenue. On growth, Volato Group, Inc. posted the faster year-over-year revenue change (13632.0% vs 47.1%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Volato Aeronaves also known as Volato Aeronaves e Compósitos Ltda is a Brazilian aircraft manufacturer.
GOSS vs SOAR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $24.9M |
| Net Profit | $-47.2M | $3.6M |
| Gross Margin | — | 15.2% |
| Operating Margin | -333.6% | 3.5% |
| Net Margin | -342.3% | 14.5% |
| Revenue YoY | 47.1% | 13632.0% |
| Net Profit YoY | -43.0% | 121.3% |
| EPS (diluted) | $-0.21 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.3M | — | ||
| Q2 25 | — | $24.9M | ||
| Q1 25 | — | $25.5M | ||
| Q3 24 | — | $38.5M | ||
| Q2 24 | $95.8M | — | ||
| Q1 24 | $0 | — | ||
| Q4 23 | — | $3.2M |
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-48.2M | — | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $455.0K | ||
| Q3 24 | — | $-4.4M | ||
| Q2 24 | $49.2M | — | ||
| Q1 24 | $-41.9M | — | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 15.2% | ||
| Q1 25 | — | 17.6% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | — | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 9.9% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | -342.3% | — | ||
| Q3 25 | -362.7% | — | ||
| Q2 25 | — | 14.5% | ||
| Q1 25 | — | 1.8% | ||
| Q3 24 | — | -11.5% | ||
| Q2 24 | 51.4% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | — | $0.75 | ||
| Q1 25 | — | $0.03 | ||
| Q3 24 | — | $-3.76 | ||
| Q2 24 | $0.22 | — | ||
| Q1 24 | $-0.19 | — | ||
| Q4 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $-7.1M |
| Total Assets | $172.2M | $13.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $354.5M | — | ||
| Q1 24 | $244.4M | — | ||
| Q4 23 | — | — |
| Q4 25 | $-122.8M | — | ||
| Q3 25 | $-82.3M | — | ||
| Q2 25 | — | $-7.1M | ||
| Q1 25 | — | $-15.8M | ||
| Q3 24 | — | $-19.6M | ||
| Q2 24 | $81.5M | — | ||
| Q1 24 | $26.7M | — | ||
| Q4 23 | — | $14.8M |
| Q4 25 | $172.2M | — | ||
| Q3 25 | $208.8M | — | ||
| Q2 25 | — | $13.0M | ||
| Q1 25 | — | $23.4M | ||
| Q3 24 | — | $47.9M | ||
| Q2 24 | $373.4M | — | ||
| Q1 24 | $259.4M | — | ||
| Q4 23 | — | $71.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $848.0K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | — | ||
| Q3 25 | $-36.2M | — | ||
| Q2 25 | — | $848.0K | ||
| Q1 25 | — | $-312.0K | ||
| Q3 24 | — | $-3.1M | ||
| Q2 24 | $116.3M | — | ||
| Q1 24 | $-52.3M | — | ||
| Q4 23 | — | $-30.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $-3.2M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $-31.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | -8.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -958.0% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 19.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | -0.69× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
